CAHILL BRIAN JOSEPH (Chief Financial Officer) received a stock award from EAGLE PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/29/2024ACC: 0001415889-24-006003
Officer· Chief Financial Officer
Since Oct 2020
+2.21K
Net shares
Net buyer
$10.2K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
3.80K acquired · 1.59K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+3.80K
Price / share
—
Trade value
—
% of position
8.3%
2/27/2024
45.75K→49.55K
Common Stock
Direct
Shares
−1.59K
Price / share
$6.44
Trade value
$10.23K
% of position
3.2%
2/27/2024
49.55K→47.96K
Total
Net shares
+2.21K
Net value
-$10.23K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/27/2024 | A · Award | +3.80K | — | — | 8.3% | 45.75K | 49.55K |
| Common Stock Direct | 2/27/2024 | F · Tax Withholding | −1.59K | $6.44 | $10.23K | 3.2% | 49.55K | 47.96K |
| Total | +2.21K | -$10.23K | ||||||
Derivative Transactions0
No derivative transactions reported